Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Tmed5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMED5 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | affects expression | ISO | Tmed5 (Mus musculus) | 6480464 | ethylene dichloride affects the expression of TMED5 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of TMED5 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of TMED5 mRNA | CTD | PMID:32145629 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of TMED5 mRNA | CTD | PMID:29581250 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Tmed5 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Tmed5 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TMED5 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TMED5 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tmed5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TMED5 mRNA | CTD | PMID:18691609 and PMID:24680724 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of TMED5 mRNA | CTD | PMID:26251327 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of TMED5 mRNA | CTD | PMID:28973697 | 4-phenylbutyric acid | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | 4-phenylbutyric acid results in increased expression of TMED5 mRNA | CTD | PMID:14583596 | 4-phenylbutyric acid | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | 4-phenylbutyric acid results in decreased expression of TMED5 mRNA | CTD | PMID:14583596 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of TMED5 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of TMED5 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of TMED5 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of TMED5 mRNA | CTD | PMID:33354967 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of TMED5 mRNA | CTD | PMID:30047161 | antirheumatic drug | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of TMED5 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of TMED5 mRNA | CTD | PMID:33212167 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TMED5 mRNA | CTD | PMID:25181051 | bisphenol A | affects expression | ISO | TMED5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of TMED5 mRNA | CTD | PMID:30903817 | bisphenol F | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of TMED5 protein | CTD | PMID:34186270 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of TMED5 mRNA | CTD | PMID:19167457 | cadmium atom | multiple interactions | ISO | Tmed5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMED5 mRNA | CTD | PMID:37325564 | cadmium dichloride | multiple interactions | ISO | Tmed5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMED5 mRNA | CTD | PMID:37325564 | caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of TMED5 mRNA | CTD | PMID:20864626 | carbon nanotube | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | carnosic acid | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | salvin results in decreased expression of TMED5 protein | CTD | PMID:35926579 | chloropicrin | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of TMED5 mRNA | CTD | PMID:28476498 | chloropicrin | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | chloropicrin results in increased expression of TMED5 mRNA | CTD | PMID:26352163 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of TMED5 mRNA | CTD | PMID:23125180 | chlorpyrifos | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of TMED5 mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | ISO | Tmed5 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of TMED5 mRNA | CTD | PMID:28472532 | ciguatoxin CTX1B | affects expression | ISO | Tmed5 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of TMED5 mRNA | CTD | PMID:18353800 | cisplatin | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of TMED5 mRNA | CTD | PMID:27392435 | clofibrate | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Clofibrate results in increased expression of TMED5 mRNA | CTD | PMID:23811191 and PMID:30629241 | clorgyline | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Clorgyline results in increased expression of TMED5 mRNA | CTD | PMID:19691856 | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of TMED5 mRNA | CTD | PMID:17898221 | copper(II) sulfate | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of TMED5 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TMED5 mRNA | CTD | PMID:20106945 | dichloroacetic acid | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of TMED5 mRNA | CTD | PMID:28962523 | disodium selenite | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of TMED5 mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | ISO | TMED5 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | entinostat results in increased expression of TMED5 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | TMED5 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMED5 mRNA | CTD | PMID:27188386 | folic acid | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of TMED5 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of TMED5 mRNA | CTD | PMID:23649840 | isotretinoin | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of TMED5 mRNA | CTD | PMID:20436886 | ivermectin | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of TMED5 protein | CTD | PMID:32959892 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of TMED5 mRNA | CTD | PMID:30047161 | methoxyacetic acid | decreases expression | EXP | | 6480464 | methoxyacetic acid results in decreased expression of TMED5 mRNA | CTD | PMID:20864626 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of TMED5 mRNA | CTD | PMID:20864626 | methylmercury chloride | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of TMED5 mRNA | CTD | PMID:28001369 | miconazole | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Miconazole results in decreased expression of TMED5 mRNA | CTD | PMID:27462272 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of TMED5 mRNA | CTD | PMID:22401849 | Monobutylphthalate | decreases expression | EXP | | 6480464 | monobutyl phthalate results in decreased expression of TMED5 mRNA | CTD | PMID:20864626 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of TMED5 mRNA | CTD | PMID:25729387 | panobinostat | multiple interactions | ISO | TMED5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMED5 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | panobinostat results in increased expression of TMED5 mRNA | CTD | PMID:26272509 | paracetamol | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of TMED5 mRNA | CTD | PMID:29067470 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TMED5 mRNA | CTD | PMID:33387578 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of TMED5 mRNA | CTD | PMID:32680482 | PCB138 | multiple interactions | ISO | Tmed5 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Tmed5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMED5 mRNA | CTD | PMID:36331819 | permethrin | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Permethrin results in increased expression of TMED5 mRNA | CTD | PMID:30629241 | phenobarbital | affects expression | ISO | Tmed5 (Mus musculus) | 6480464 | Phenobarbital affects the expression of TMED5 mRNA | CTD | PMID:23091169 | phenylmercury acetate | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of TMED5 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TMED5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMED5 mRNA | CTD | PMID:27188386 | pirinixic acid | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of TMED5 mRNA | CTD | PMID:18301758 more ... | resveratrol | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | resveratrol results in increased expression of TMED5 protein | CTD | PMID:25505154 | SB 431542 | multiple interactions | ISO | TMED5 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of TMED5 mRNA | CTD | PMID:34032870 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of TMED5 mRNA | CTD | PMID:30047161 | tetrachloroethene | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of TMED5 mRNA | CTD | PMID:28973375 | tetrachloromethane | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of TMED5 mRNA | CTD | PMID:27339419 and PMID:31919559 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of TMED5 mRNA | CTD | PMID:34492290 | titanium dioxide | affects expression | ISO | TMED5 (Homo sapiens) | 6480464 | titanium dioxide affects the expression of TMED5 mRNA | CTD | PMID:24023007 | titanium dioxide | decreases expression | ISO | Tmed5 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of TMED5 mRNA | CTD | PMID:29264374 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of TMED5 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of TMED5 mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of TMED5 mRNA | CTD | PMID:25549359 and PMID:28973375 | triptonide | increases expression | ISO | Tmed5 (Mus musculus) | 6480464 | triptonide results in increased expression of TMED5 mRNA | CTD | PMID:33045310 | tunicamycin | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of TMED5 mRNA | CTD | PMID:22378314 | valproic acid | decreases methylation | ISO | TMED5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of TMED5 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | TMED5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMED5 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TMED5 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | Tmed5 (Mus musculus) | 6480464 | Valproic Acid affects the expression of TMED5 mRNA | CTD | PMID:17292431 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TMED5 mRNA | CTD | PMID:23555832 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of TMED5 mRNA | CTD | PMID:23869203 | vorinostat | increases expression | ISO | TMED5 (Homo sapiens) | 6480464 | vorinostat results in increased expression of TMED5 mRNA | CTD | PMID:27188386 | xylitol | decreases expression | ISO | TMED5 (Homo sapiens) | 6480464 | Xylitol results in decreased expression of TMED5 mRNA | CTD | PMID:32275922 | |